Noble Life Sciences

company

About

Noble Life Sciences provides preclinical contract services for clients in the biotech and pharmaceutical industries as well as academia.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$100K
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Noble Life Sciences provides high-quality, preclinical contract services that help you get from concept to clinic faster and more efficiently. We have a state-of-the-art laboratory facility and vivarium managed by an experienced staff. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your drug development programs through each phase of the preclinical process. In addition, Noble offers a range of services for production of protein drug candidates in mammalian and microbial systems – from development of expression vectors and stable cell lines to growth medium optimization, protein purification, analytical services and process scale-up.

With proof of concept studies, early safety assessments and other pre-IND services, we are committed to providing a strong scientific foundation to empower your preclinical decisions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100K
Noble Life Sciences has raised a total of $100K in funding over 2 rounds. Their latest funding was raised on Jan 15, 2014 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 15, 2014 Seed $100K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Noble Life Sciences is funded by 1 investors. TEDCO are the most recent investors.
Investor Name Lead Investor Funding Round
TEDCO Seed